Reva Medical (ASX:RVA) said this week that it won CE Mark clearance for its entire line of Fantom Encore bioresorbable, drug-eluting scaffolds.
The new approval covers Reva’s Fantom 3.0 and 3.5 mm diameter devices, helping the company expand beyond its already-approved 2.5 mm diameter scaffold.
Get the full story at our sister site, Drug Delivery Business News.
The post Reva Medical wins CE Mark for full line of Fantom Encore bioresorbable scaffolds appeared first on MassDevice.
from MassDevice https://ift.tt/2I8Gbkc
Cap comentari:
Publica un comentari a l'entrada